David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
CALL
Organon & Co
OGN
$3.61B
| $230K | ﹤0.01% |
7,020
| – | – |
|
4352
Avita Medical
RCEL
$312M
| $230K | ﹤0.01% |
12,966
+2,969
| +30% | +$56K |
|
|
VOXX
4353
DELISTED
VOXX International Corporation Class A
VOXX
| $230K | ﹤0.01% |
20,073
-21,438
| -52% | -$245K |
|
|
VRS
4354
DELISTED
Verso Corporation
VRS
| $230K | ﹤0.01% |
11,063
-22,853
| -67% | -$441K |
|
|
RCOR
4355
DELISTED
Renovacor, Inc.
RCOR
| $229K | ﹤0.01% |
25,321
| – | – |
|
4356
Farmers National Banc Corp
FMNB
$931M
| $228K | ﹤0.01% |
14,486
+68
| +0.5% | +$1.04K |
|
4357
Edgewise Therapeutics
EWTX
$4.94B
| $227K | ﹤0.01% |
13,695
-32,472
| -70% | -$587K |
|
4358
Spyre Therapeutics
SYRE
$9.54B
| $227K | ﹤0.01% |
1,140
-699
| -38% | -$122K |
|
4359
German American Bancorp
GABC
$1.89B
| $226K | ﹤0.01% |
+5,846
| New | +$217K |
|
|
IAS
4360
DELISTED
Integral Ad Science
IAS
| $225K | ﹤0.01% |
+10,924
| New | +$215K |
|
|
NPTN
4361
DELISTED
NEOPHOTONICS CORP
NPTN
| $225K | ﹤0.01% |
+25,877
| New | +$236K |
|
4362
Natural Gas Services Group
NGS
$454M
| $224K | ﹤0.01% |
21,561
-2,845
| -12% | -$27.9K |
|
|
ORGN
4363
DELISTED
Origin Materials
ORGN
| $224K | ﹤0.01% |
1,098
-10,569
| -91% | -$2.18M |
|
|
AIFU
4364
AIFU Inc
AIFU
$132M
| $224K | ﹤0.01% |
46
-34
| -43% | -$189K |
|
4365
Allstate
ALL
$65.6B
| $223K | ﹤0.01% |
1,750
-7,555
| -81% | -$998K |
|
4366
Graham Corp
GHM
$1.15B
| $223K | ﹤0.01% |
17,972
-5,763
| -24% | -$74.4K |
|
|
TBIO
4367
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $222K | ﹤0.01% |
+1,108
| New | +$281K |
|
4368
Clarus
CLAR
$146M
| $221K | ﹤0.01% |
8,626
-31,365
| -78% | -$866K |
|
|
DM
4369
DELISTED
Desktop Metal, Inc.
DM
| $220K | ﹤0.01% |
+3,068
| New | +$266K |
|
4370
KBR
KBR
$4.74B
| $219K | ﹤0.01% |
5,547
-55,433
| -91% | -$2.15M |
|
4371
Pennant Group
PNTG
$1.36B
| $219K | ﹤0.01% |
+7,810
| New | +$255K |
|
4372
eGain
EGAN
$199M
| $218K | ﹤0.01% |
21,380
-9,764
| -31% | -$110K |
|
4373
The Joint Corp
JYNT
$120M
| $218K | ﹤0.01% |
2,229
-1,204
| -35% | -$113K |
|
|
RDFN
4374
DELISTED
Redfin
RDFN
| $218K | ﹤0.01% |
+4,361
| New | +$236K |
|
|
NESR
4375
National Energy Services Reunited Corp
NESR
$3.41B
| $218K | ﹤0.01% |
17,391
-81,429
| -82% | -$991K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.